Registrieren
E-Mail:
Passwort:
Ich akzeptiere die
Nutzungsbedingungen
Registrieren
Registierung erfolgt in Kürze...
query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.finanzen.ch/nachrichten/aktien/nestle-to-sell-mainstream-vms-business-to-yellow-wood-for-$1-bln-1036513453
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
Nestle To Sell Mainstream VMS Business To Yellow Wood For $1 Bln | 02.09.26 | finanzen.ch
(RTTNews) - Nestlé (NSTR.L, NESN.SW) on Tuesday said it has agreed to divest its mainstream Vitamins, Minerals and Supplements (VMS) business, the...
Videos
ABB, Hochtief & Schneider Electric: Welche Aktie überzeugt bei Kennzahlen und Bewertung?
11 Minuten 42 Sekunden
Ähnliche Seiten
Nestle To Sell Mainstream VMS Business To Yellow Wood For $1 Bln | 02.09.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/nestle-to-sell-mainstream-vms-business-to-yellow-wood-for-$1-bln-1036513453
Swiss food giant Nestle sells supplements business to US firm for $1 billion
https://www.thelocal.ch/20260902/swiss-food-giant-nestle-sells-supplements-business-to-us-firm-for-1-billion
Press Release: Nestle: Nestlé reaches agreement to divest its mainstream vitamins, minerals and supplements business | 01.09.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/press-release-nestle-nestle-reaches-agreement-to-divest-its-mainstream-vitamins-minerals-and-supplements-business-1036512394
Nestle to divest mainstream supplements business for $1 billion - The Economic Times
https://economictimes.indiatimes.com/industry/cons-products/nestle-to-divest-mainstream-supplements-business-for-1-billion/articleshow/133689701.cms
Press Release: Nestle: Nestlé reaches agreement to divest its mainstream vitamins, minerals and supplements business | 01.09.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/press-release-nestle-nestle-reaches-agreement-to-divest-its-mainstream-vitamins-minerals-and-supplements-business-1036512396
Edgewise Therapeutics To Sell Muscular Dystrophy Business & Sevasemten For Up To $2.65 Bln | 01.06.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/edgewise-therapeutics-to-sell-muscular-dystrophy-business-&-sevasemten-for-up-to-$2-65-bln-1036213040
Please enable JavaScript to continue using this application.